

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.32205512 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.32205512 |
| 3 | * positive regulation of gamma-delta T cell activation (GO:0046645) | 5.77286793 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.67642084 |
| 5 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.54169752 |
| 6 | negative T cell selection (GO:0043383) | 5.46243936 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.45413558 |
| 8 | positive thymic T cell selection (GO:0045059) | 5.43478906 |
| 9 | negative thymic T cell selection (GO:0045060) | 5.35344140 |
| 10 | ribosomal small subunit assembly (GO:0000028) | 5.05533498 |
| 11 | * regulation of gamma-delta T cell differentiation (GO:0045586) | 4.99821099 |
| 12 | response to interleukin-15 (GO:0070672) | 4.96556450 |
| 13 | interferon-gamma production (GO:0032609) | 4.86964073 |
| 14 | cellular response to interleukin-15 (GO:0071350) | 4.81131680 |
| 15 | positive T cell selection (GO:0043368) | 4.62686224 |
| 16 | thymic T cell selection (GO:0045061) | 4.59619637 |
| 17 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.50519884 |
| 18 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.46941629 |
| 19 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.46227531 |
| 20 | * regulation of gamma-delta T cell activation (GO:0046643) | 4.42137786 |
| 21 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.38276166 |
| 22 | negative regulation of T cell mediated immunity (GO:0002710) | 4.33594453 |
| 23 | tolerance induction (GO:0002507) | 4.23512671 |
| 24 | activated T cell proliferation (GO:0050798) | 4.21778365 |
| 25 | T cell selection (GO:0045058) | 4.21610546 |
| 26 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.19885020 |
| 27 | T cell migration (GO:0072678) | 4.11646023 |
| 28 | leukocyte aggregation (GO:0070486) | 3.99225618 |
| 29 | viral transcription (GO:0019083) | 3.93185991 |
| 30 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.84631774 |
| 31 | T cell receptor signaling pathway (GO:0050852) | 3.84373041 |
| 32 | positive regulation of tolerance induction (GO:0002645) | 3.84236401 |
| 33 | detection of other organism (GO:0098543) | 3.80901794 |
| 34 | response to type I interferon (GO:0034340) | 3.80054474 |
| 35 | mast cell activation (GO:0045576) | 3.77013170 |
| 36 | detection of bacterium (GO:0016045) | 3.76625715 |
| 37 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.75346869 |
| 38 | mature B cell differentiation (GO:0002335) | 3.74552009 |
| 39 | response to interferon-beta (GO:0035456) | 3.74127202 |
| 40 | modulation by symbiont of host immune response (GO:0052553) | 3.73832524 |
| 41 | positive regulation by symbiont of host defense response (GO:0052509) | 3.73832524 |
| 42 | modulation by symbiont of host defense response (GO:0052031) | 3.73832524 |
| 43 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.73832524 |
| 44 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.73832524 |
| 45 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.73832524 |
| 46 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.73817014 |
| 47 | translational termination (GO:0006415) | 3.72454427 |
| 48 | type I interferon signaling pathway (GO:0060337) | 3.72150412 |
| 49 | cellular response to type I interferon (GO:0071357) | 3.72150412 |
| 50 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.70103388 |
| 51 | mature B cell differentiation involved in immune response (GO:0002313) | 3.69185615 |
| 52 | negative regulation of interleukin-12 production (GO:0032695) | 3.68177147 |
| 53 | B cell receptor signaling pathway (GO:0050853) | 3.66808112 |
| 54 | negative regulation of cell killing (GO:0031342) | 3.66482372 |
| 55 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.66482372 |
| 56 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.63677961 |
| 57 | megakaryocyte development (GO:0035855) | 3.63034571 |
| 58 | regulation of B cell differentiation (GO:0045577) | 3.61903174 |
| 59 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.60350673 |
| 60 | definitive hemopoiesis (GO:0060216) | 3.58318474 |
| 61 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.57216693 |
| 62 | T cell costimulation (GO:0031295) | 3.53403091 |
| 63 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.52946295 |
| 64 | lymphocyte costimulation (GO:0031294) | 3.52451657 |
| 65 | regulation of response to interferon-gamma (GO:0060330) | 3.50929222 |
| 66 | positive regulation of B cell differentiation (GO:0045579) | 3.50693294 |
| 67 | defense response to protozoan (GO:0042832) | 3.49522111 |
| 68 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.47766709 |
| 69 | response to protozoan (GO:0001562) | 3.47535057 |
| 70 | regulation of T cell tolerance induction (GO:0002664) | 3.45533361 |
| 71 | lymph node development (GO:0048535) | 3.43753761 |
| 72 | positive regulation of isotype switching (GO:0045830) | 3.42022009 |
| 73 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.42003941 |
| 74 | neutrophil activation involved in immune response (GO:0002283) | 3.39337086 |
| 75 | regulation of tolerance induction (GO:0002643) | 3.37363995 |
| 76 | dendritic cell chemotaxis (GO:0002407) | 3.33333522 |
| 77 | immunoglobulin mediated immune response (GO:0016064) | 3.32892218 |
| 78 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.28052775 |
| 79 | cellular extravasation (GO:0045123) | 3.27413470 |
| 80 | positive regulation of granulocyte differentiation (GO:0030854) | 3.25809809 |
| 81 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.25272925 |
| 82 | natural killer cell activation (GO:0030101) | 3.24778673 |
| 83 | translational elongation (GO:0006414) | 3.24756898 |
| 84 | macrophage activation involved in immune response (GO:0002281) | 3.22579805 |
| 85 | Peyers patch development (GO:0048541) | 3.21257193 |
| 86 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.21257193 |
| 87 | ribosomal small subunit biogenesis (GO:0042274) | 3.21145871 |
| 88 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.18322828 |
| 89 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.17591937 |
| 90 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.17183179 |
| 91 | * T cell differentiation (GO:0030217) | 3.16135289 |
| 92 | dendritic cell migration (GO:0036336) | 3.14332385 |
| 93 | positive regulation of DNA recombination (GO:0045911) | 3.11976379 |
| 94 | negative regulation of innate immune response (GO:0045824) | 3.11311213 |
| 95 | * regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.11007604 |
| 96 | detection of external biotic stimulus (GO:0098581) | 3.10944158 |
| 97 | lymphocyte migration (GO:0072676) | 3.10847803 |
| 98 | positive regulation of interleukin-2 production (GO:0032743) | 3.10502947 |
| 99 | * regulation of cell killing (GO:0031341) | 3.09932507 |
| 100 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.09687071 |
| 101 | positive regulation of immunoglobulin production (GO:0002639) | 3.08833481 |
| 102 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.08681686 |
| 103 | * regulation of regulatory T cell differentiation (GO:0045589) | 3.08255744 |
| 104 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.07038828 |
| 105 | NIK/NF-kappaB signaling (GO:0038061) | 3.06107535 |
| 106 | neutrophil activation (GO:0042119) | 3.04651520 |
| 107 | alpha-beta T cell activation (GO:0046631) | 3.01460787 |
| 108 | * T cell homeostasis (GO:0043029) | 3.01130006 |
| 109 | alpha-beta T cell differentiation (GO:0046632) | 3.00888722 |
| 110 | germinal center formation (GO:0002467) | 2.99754967 |
| 111 | cotranslational protein targeting to membrane (GO:0006613) | 2.99703331 |
| 112 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.99413156 |
| 113 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.99290592 |
| 114 | respiratory burst (GO:0045730) | 2.99254881 |
| 115 | protein targeting to ER (GO:0045047) | 2.99223987 |
| 116 | regulation of isotype switching (GO:0045191) | 2.98927025 |
| 117 | mast cell activation involved in immune response (GO:0002279) | 2.97305246 |
| 118 | mast cell degranulation (GO:0043303) | 2.97305246 |
| 119 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.95837719 |
| 120 | cellular response to interferon-beta (GO:0035458) | 2.95522057 |
| 121 | lymphocyte chemotaxis (GO:0048247) | 2.94732429 |
| 122 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.94330195 |
| 123 | viral life cycle (GO:0019058) | 2.93138496 |
| 124 | regulation of T cell mediated immunity (GO:0002709) | 2.92665981 |
| 125 | myeloid cell activation involved in immune response (GO:0002275) | 2.91895396 |
| 126 | * regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.91819582 |
| 127 | * positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.91734676 |
| 128 | leukocyte cell-cell adhesion (GO:0007159) | 2.89857778 |
| 129 | * positive regulation of cell killing (GO:0031343) | 2.89808687 |
| 130 | * T cell activation (GO:0042110) | 2.89372194 |
| 131 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.85284925 |
| 132 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.84211203 |
| 133 | granulocyte activation (GO:0036230) | 2.84002552 |
| 134 | * regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.83988759 |
| 135 | * regulation of natural killer cell mediated immunity (GO:0002715) | 2.83988759 |
| 136 | negative regulation of adaptive immune response (GO:0002820) | 2.83346735 |
| 137 | protein localization to endoplasmic reticulum (GO:0070972) | 2.83204591 |
| 138 | regulation of immunoglobulin production (GO:0002637) | 2.83165663 |
| 139 | * regulation of alpha-beta T cell activation (GO:0046634) | 2.80352447 |
| 140 | cytidine catabolic process (GO:0006216) | 2.80132429 |
| 141 | cytidine deamination (GO:0009972) | 2.80132429 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.72479197 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.90595066 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.52790505 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.10908667 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.49731455 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.47457809 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.39587287 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 3.32993388 |
| 9 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.12880280 |
| 10 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.10436446 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.07995917 |
| 12 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.96336140 |
| 13 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.93875155 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.93440025 |
| 15 | MYB_26560356_Chip-Seq_TH2_Human | 2.82465764 |
| 16 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.77917824 |
| 17 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.76751536 |
| 18 | * MAF_26560356_Chip-Seq_TH1_Human | 2.61863682 |
| 19 | MYB_26560356_Chip-Seq_TH1_Human | 2.50338651 |
| 20 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.46681341 |
| 21 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.39444085 |
| 22 | UTX_26944678_Chip-Seq_JUKART_Human | 2.39311127 |
| 23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.37965825 |
| 24 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.35618446 |
| 25 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.34296861 |
| 26 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.24859314 |
| 27 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.23146945 |
| 28 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.22403820 |
| 29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.06920536 |
| 30 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.03691285 |
| 31 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99665187 |
| 32 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.94623393 |
| 33 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.88950773 |
| 34 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.87396898 |
| 35 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.85301805 |
| 36 | MAF_26560356_Chip-Seq_TH2_Human | 1.83783731 |
| 37 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82999377 |
| 38 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.81896181 |
| 39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.80793300 |
| 40 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.80137342 |
| 41 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.78564212 |
| 42 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.76917220 |
| 43 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.75915995 |
| 44 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.67050688 |
| 45 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.65359164 |
| 46 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.63094901 |
| 47 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.62105054 |
| 48 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.59568395 |
| 49 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.50852586 |
| 50 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.50425360 |
| 51 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.46904037 |
| 52 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.46507861 |
| 53 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45557334 |
| 54 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.45462181 |
| 55 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.43689693 |
| 56 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.43021076 |
| 57 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.37807109 |
| 58 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.37510561 |
| 59 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.36758492 |
| 60 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.36306784 |
| 61 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.35633869 |
| 62 | SPI1_23127762_ChIP-Seq_K562_Human | 1.35222034 |
| 63 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.34655102 |
| 64 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.34435889 |
| 65 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.32528770 |
| 66 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.31480798 |
| 67 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.30614586 |
| 68 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.27926016 |
| 69 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.24912864 |
| 70 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.19357742 |
| 71 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.18558425 |
| 72 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.18422782 |
| 73 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.17872592 |
| 74 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.15410156 |
| 75 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.15182597 |
| 76 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.13325674 |
| 77 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12461928 |
| 78 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11139881 |
| 79 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10231671 |
| 80 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.07462330 |
| 81 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07239791 |
| 82 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.07143833 |
| 83 | GATA3_26560356_Chip-Seq_TH2_Human | 1.07009959 |
| 84 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.05683981 |
| 85 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04535501 |
| 86 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01988345 |
| 87 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.01797885 |
| 88 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.00428785 |
| 89 | GATA1_22025678_ChIP-Seq_K562_Human | 1.00063358 |
| 90 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.00008144 |
| 91 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.98720196 |
| 92 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97686886 |
| 93 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97402402 |
| 94 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95635256 |
| 95 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94944000 |
| 96 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.93744752 |
| 97 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.91126717 |
| 98 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.90827965 |
| 99 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90764033 |
| 100 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90502587 |
| 101 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.89419526 |
| 102 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88436906 |
| 103 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81753594 |
| 104 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.80105517 |
| 105 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79951379 |
| 106 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79859279 |
| 107 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79458565 |
| 108 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.79420685 |
| 109 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.79212429 |
| 110 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.79085570 |
| 111 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.78237238 |
| 112 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.77827943 |
| 113 | GATA2_19941826_ChIP-Seq_K562_Human | 0.77259414 |
| 114 | GATA1_19941826_ChIP-Seq_K562_Human | 0.76915711 |
| 115 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.76197651 |
| 116 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.75440157 |
| 117 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.75093112 |
| 118 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.74891094 |
| 119 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.74490101 |
| 120 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.73441049 |
| 121 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.73021071 |
| 122 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.71990554 |
| 123 | GATA3_26560356_Chip-Seq_TH1_Human | 0.71969597 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 4.18599801 |
| 2 | * MP0005671_abnormal_response_to | 4.03038237 |
| 3 | MP0000685_abnormal_immune_system | 3.79372272 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.73067906 |
| 5 | * MP0001800_abnormal_humoral_immune | 3.23343650 |
| 6 | MP0009785_altered_susceptibility_to | 3.01507906 |
| 7 | MP0003724_increased_susceptibility_to | 3.00372775 |
| 8 | MP0005387_immune_system_phenotype | 2.91302860 |
| 9 | MP0001790_abnormal_immune_system | 2.91302860 |
| 10 | MP0002396_abnormal_hematopoietic_system | 2.90498547 |
| 11 | * MP0002398_abnormal_bone_marrow | 2.77348342 |
| 12 | * MP0002420_abnormal_adaptive_immunity | 2.76264511 |
| 13 | * MP0002723_abnormal_immune_serum | 2.71976662 |
| 14 | * MP0001819_abnormal_immune_cell | 2.70958439 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.69589345 |
| 16 | MP0002166_altered_tumor_susceptibility | 2.66084625 |
| 17 | * MP0002452_abnormal_antigen_presenting | 2.65748159 |
| 18 | MP0005025_abnormal_response_to | 2.53016728 |
| 19 | MP0001873_stomach_inflammation | 2.42478980 |
| 20 | * MP0000716_abnormal_immune_system | 2.37900056 |
| 21 | MP0003436_decreased_susceptibility_to | 2.30234671 |
| 22 | * MP0000689_abnormal_spleen_morphology | 2.23844855 |
| 23 | * MP0002722_abnormal_immune_system | 2.23556783 |
| 24 | MP0005464_abnormal_platelet_physiology | 2.19698101 |
| 25 | * MP0004808_abnormal_hematopoietic_stem | 2.19493893 |
| 26 | MP0002405_respiratory_system_inflammati | 2.15788798 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 2.15068438 |
| 28 | * MP0000703_abnormal_thymus_morphology | 2.13160688 |
| 29 | * MP0010155_abnormal_intestine_physiology | 2.10836431 |
| 30 | MP0002006_tumorigenesis | 2.06264789 |
| 31 | * MP0002429_abnormal_blood_cell | 2.05437566 |
| 32 | MP0002148_abnormal_hypersensitivity_rea | 2.00082148 |
| 33 | MP0006082_CNS_inflammation | 1.97170605 |
| 34 | MP0000465_gastrointestinal_hemorrhage | 1.92490867 |
| 35 | MP0003300_gastrointestinal_ulcer | 1.90431944 |
| 36 | MP0001853_heart_inflammation | 1.86899036 |
| 37 | MP0002419_abnormal_innate_immunity | 1.86207976 |
| 38 | MP0001545_abnormal_hematopoietic_system | 1.86052580 |
| 39 | MP0005397_hematopoietic_system_phenotyp | 1.86052580 |
| 40 | * MP0003866_abnormal_defecation | 1.78853154 |
| 41 | MP0010368_abnormal_lymphatic_system | 1.77372661 |
| 42 | MP0005075_abnormal_melanosome_morpholog | 1.67422614 |
| 43 | MP0004947_skin_inflammation | 1.66303742 |
| 44 | * MP0001845_abnormal_inflammatory_respons | 1.60015875 |
| 45 | MP0004510_myositis | 1.48914037 |
| 46 | MP0002933_joint_inflammation | 1.42579264 |
| 47 | MP0001879_abnormal_lymphatic_vessel | 1.42283578 |
| 48 | MP0006054_spinal_hemorrhage | 1.36243055 |
| 49 | MP0005174_abnormal_tail_pigmentation | 1.33738890 |
| 50 | MP0009278_abnormal_bone_marrow | 1.32508286 |
| 51 | MP0008260_abnormal_autophagy | 1.30227895 |
| 52 | MP0003172_abnormal_lysosome_physiology | 1.29625247 |
| 53 | MP0003303_peritoneal_inflammation | 1.20844588 |
| 54 | * MP0008469_abnormal_protein_level | 1.14536187 |
| 55 | * MP0000490_abnormal_crypts_of | 1.14231029 |
| 56 | MP0002277_abnormal_respiratory_mucosa | 1.14033179 |
| 57 | MP0005451_abnormal_body_composition | 1.11800358 |
| 58 | MP0003828_pulmonary_edema | 1.07354097 |
| 59 | MP0004147_increased_porphyrin_level | 1.06765575 |
| 60 | MP0004883_abnormal_blood_vessel | 1.06149852 |
| 61 | MP0002019_abnormal_tumor_incidence | 1.06087273 |
| 62 | MP0001533_abnormal_skeleton_physiology | 1.04958094 |
| 63 | MP0002132_abnormal_respiratory_system | 1.04330462 |
| 64 | MP0003448_altered_tumor_morphology | 1.03452792 |
| 65 | MP0001986_abnormal_taste_sensitivity | 1.02870725 |
| 66 | MP0000858_altered_metastatic_potential | 1.01374857 |
| 67 | MP0001851_eye_inflammation | 1.01252997 |
| 68 | MP0002009_preneoplasia | 0.96989694 |
| 69 | MP0005310_abnormal_salivary_gland | 0.95129339 |
| 70 | MP0003690_abnormal_glial_cell | 0.95025778 |
| 71 | MP0000604_amyloidosis | 0.93528894 |
| 72 | MP0009379_abnormal_foot_pigmentation | 0.92604538 |
| 73 | MP0004130_abnormal_muscle_cell | 0.91596254 |
| 74 | MP0002095_abnormal_skin_pigmentation | 0.91539920 |
| 75 | * MP0003943_abnormal_hepatobiliary_system | 0.90807394 |
| 76 | MP0008058_abnormal_DNA_repair | 0.86803352 |
| 77 | MP0003183_abnormal_peptide_metabolism | 0.85752478 |
| 78 | MP0009763_increased_sensitivity_to | 0.81943640 |
| 79 | MP0008007_abnormal_cellular_replicative | 0.79324740 |
| 80 | MP0005164_abnormal_response_to | 0.78895591 |
| 81 | MP0009764_decreased_sensitivity_to | 0.77788922 |
| 82 | MP0003075_altered_response_to | 0.76836312 |
| 83 | MP0009765_abnormal_xenobiotic_induced | 0.75481609 |
| 84 | MP0003077_abnormal_cell_cycle | 0.74141040 |
| 85 | MP0000249_abnormal_blood_vessel | 0.73361365 |
| 86 | MP0005390_skeleton_phenotype | 0.70781409 |
| 87 | MP0004381_abnormal_hair_follicle | 0.70203642 |
| 88 | MP0005023_abnormal_wound_healing | 0.69777688 |
| 89 | MP0001663_abnormal_digestive_system | 0.68691917 |
| 90 | MP0008057_abnormal_DNA_replication | 0.67798836 |
| 91 | MP0003279_aneurysm | 0.67387837 |
| 92 | MP0001348_abnormal_lacrimal_gland | 0.67192635 |
| 93 | MP0005167_abnormal_blood-brain_barrier | 0.66841122 |
| 94 | MP0000343_altered_response_to | 0.66758207 |
| 95 | MP0003191_abnormal_cellular_cholesterol | 0.66201302 |
| 96 | MP0002998_abnormal_bone_remodeling | 0.63633679 |
| 97 | MP0003045_fibrosis | 0.63174144 |
| 98 | MP0002138_abnormal_hepatobiliary_system | 0.62762780 |
| 99 | MP0005058_abnormal_lysosome_morphology | 0.62318924 |
| 100 | MP0009840_abnormal_foam_cell | 0.61774504 |
| 101 | MP0000015_abnormal_ear_pigmentation | 0.60951480 |
| 102 | MP0002693_abnormal_pancreas_physiology | 0.59916991 |
| 103 | MP0010094_abnormal_chromosome_stability | 0.59401693 |
| 104 | MP0008004_abnormal_stomach_pH | 0.58842675 |
| 105 | MP0000313_abnormal_cell_death | 0.57932606 |
| 106 | MP0001191_abnormal_skin_condition | 0.57687648 |
| 107 | MP0008874_decreased_physiological_sensi | 0.57446323 |
| 108 | * MP0000477_abnormal_intestine_morphology | 0.56975125 |
| 109 | MP0002136_abnormal_kidney_physiology | 0.55420873 |
| 110 | MP0005381_digestive/alimentary_phenotyp | 0.53874229 |
| 111 | MP0003693_abnormal_embryo_hatching | 0.52944022 |
| 112 | MP0000767_abnormal_smooth_muscle | 0.51758646 |
| 113 | MP0003091_abnormal_cell_migration | 0.50101591 |
| 114 | * MP0000598_abnormal_liver_morphology | 0.49605439 |
| 115 | MP0002163_abnormal_gland_morphology | 0.49347573 |
| 116 | MP0010352_gastrointestinal_tract_polyps | 0.48997503 |
| 117 | MP0008961_abnormal_basal_metabolism | 0.48484703 |
| 118 | MP0002128_abnormal_blood_circulation | 0.47408643 |
| 119 | MP0009115_abnormal_fat_cell | 0.46761202 |
| 120 | MP0003795_abnormal_bone_structure | 0.46580724 |
| 121 | MP0000609_abnormal_liver_physiology | 0.45832710 |
| 122 | MP0003646_muscle_fatigue | 0.45092666 |
| 123 | MP0002254_reproductive_system_inflammat | 0.43471996 |
| 124 | MP0008873_increased_physiological_sensi | 0.43244371 |
| 125 | MP0004957_abnormal_blastocyst_morpholog | 0.42880827 |
| 126 | MP0005166_decreased_susceptibility_to | 0.42842956 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.31692405 |
| 2 | Recurrent bronchitis (HP:0002837) | 4.92030642 |
| 3 | IgM deficiency (HP:0002850) | 4.87809681 |
| 4 | T lymphocytopenia (HP:0005403) | 4.77234909 |
| 5 | Myositis (HP:0100614) | 4.68112111 |
| 6 | Abnormality of T cell number (HP:0011839) | 4.58237620 |
| 7 | Abnormality of the nasal mucosa (HP:0000433) | 4.54987693 |
| 8 | Thrombocytosis (HP:0001894) | 4.45245092 |
| 9 | Abnormality of macrophages (HP:0004311) | 4.43865538 |
| 10 | Chronic otitis media (HP:0000389) | 4.34008388 |
| 11 | Abnormality of T cells (HP:0002843) | 4.16846368 |
| 12 | Agammaglobulinemia (HP:0004432) | 4.10922896 |
| 13 | Panhypogammaglobulinemia (HP:0003139) | 4.04477826 |
| 14 | Spontaneous hematomas (HP:0007420) | 4.00553998 |
| 15 | Nasal polyposis (HP:0100582) | 3.94770765 |
| 16 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.83569763 |
| 17 | IgG deficiency (HP:0004315) | 3.83055730 |
| 18 | Recurrent viral infections (HP:0004429) | 3.70766281 |
| 19 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.67258230 |
| 20 | Lymphopenia (HP:0001888) | 3.65117524 |
| 21 | Inflammation of the large intestine (HP:0002037) | 3.60810767 |
| 22 | Recurrent fungal infections (HP:0002841) | 3.56638385 |
| 23 | Gastrointestinal inflammation (HP:0004386) | 3.56430464 |
| 24 | Severe combined immunodeficiency (HP:0004430) | 3.53575785 |
| 25 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.48811927 |
| 26 | Obstructive lung disease (HP:0006536) | 3.45314143 |
| 27 | Chronic obstructive pulmonary disease (HP:0006510) | 3.45314143 |
| 28 | B lymphocytopenia (HP:0010976) | 3.39602059 |
| 29 | Abnormality of B cell number (HP:0010975) | 3.39602059 |
| 30 | Abnormality of T cell physiology (HP:0011840) | 3.37879686 |
| 31 | Prolonged bleeding time (HP:0003010) | 3.37307496 |
| 32 | Abnormality of the fingertips (HP:0001211) | 3.31895755 |
| 33 | Gastrointestinal stroma tumor (HP:0100723) | 3.30354612 |
| 34 | Meningitis (HP:0001287) | 3.30325659 |
| 35 | Petechiae (HP:0000967) | 3.26039036 |
| 36 | Recurrent cutaneous fungal infections (HP:0011370) | 3.24057740 |
| 37 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.24057740 |
| 38 | Combined immunodeficiency (HP:0005387) | 3.22863832 |
| 39 | Colitis (HP:0002583) | 3.22400925 |
| 40 | Epistaxis (HP:0000421) | 3.19559745 |
| 41 | Retrobulbar optic neuritis (HP:0100654) | 3.12397105 |
| 42 | Optic neuritis (HP:0100653) | 3.12397105 |
| 43 | Vasculitis (HP:0002633) | 3.12042563 |
| 44 | Pustule (HP:0200039) | 3.10956377 |
| 45 | Orchitis (HP:0100796) | 3.10067605 |
| 46 | Stomatitis (HP:0010280) | 3.04005933 |
| 47 | Gingivitis (HP:0000230) | 2.99586882 |
| 48 | Encephalitis (HP:0002383) | 2.95257154 |
| 49 | IgA deficiency (HP:0002720) | 2.92335844 |
| 50 | Autoimmune hemolytic anemia (HP:0001890) | 2.91950514 |
| 51 | Chronic diarrhea (HP:0002028) | 2.89846890 |
| 52 | Hemoptysis (HP:0002105) | 2.85324959 |
| 53 | Thyroiditis (HP:0100646) | 2.84737526 |
| 54 | Lymphoma (HP:0002665) | 2.84165599 |
| 55 | Aplastic anemia (HP:0001915) | 2.83240157 |
| 56 | Bronchitis (HP:0012387) | 2.81351175 |
| 57 | Recurrent abscess formation (HP:0002722) | 2.78873587 |
| 58 | Amaurosis fugax (HP:0100576) | 2.77196210 |
| 59 | Eczematoid dermatitis (HP:0000976) | 2.76793362 |
| 60 | Cellulitis (HP:0100658) | 2.74865175 |
| 61 | Abnormality of eosinophils (HP:0001879) | 2.72175652 |
| 62 | Microcytic anemia (HP:0001935) | 2.68236925 |
| 63 | Recurrent sinusitis (HP:0011108) | 2.68196429 |
| 64 | Arterial thrombosis (HP:0004420) | 2.59350175 |
| 65 | Urticaria (HP:0001025) | 2.58472401 |
| 66 | Autoimmune thrombocytopenia (HP:0001973) | 2.56508734 |
| 67 | Leukocytosis (HP:0001974) | 2.56171965 |
| 68 | Hematochezia (HP:0002573) | 2.54135210 |
| 69 | Hypochromic anemia (HP:0001931) | 2.52119106 |
| 70 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.51475544 |
| 71 | Anorexia (HP:0002039) | 2.50487989 |
| 72 | Chronic sinusitis (HP:0011109) | 2.50458128 |
| 73 | Mediastinal lymphadenopathy (HP:0100721) | 2.48685829 |
| 74 | Abnormal platelet function (HP:0011869) | 2.45389602 |
| 75 | Impaired platelet aggregation (HP:0003540) | 2.45389602 |
| 76 | Basal cell carcinoma (HP:0002671) | 2.45235118 |
| 77 | Pulmonary infiltrates (HP:0002113) | 2.44965464 |
| 78 | Joint swelling (HP:0001386) | 2.44787749 |
| 79 | Recurrent skin infections (HP:0001581) | 2.44364358 |
| 80 | Chest pain (HP:0100749) | 2.42369813 |
| 81 | Abnormal number of erythroid precursors (HP:0012131) | 2.41764120 |
| 82 | Papilledema (HP:0001085) | 2.40194132 |
| 83 | Pulmonary embolism (HP:0002204) | 2.39140062 |
| 84 | Muscle fiber atrophy (HP:0100295) | 2.36465657 |
| 85 | Gangrene (HP:0100758) | 2.35900061 |
| 86 | Type 2 muscle fiber atrophy (HP:0003554) | 2.33693011 |
| 87 | Granulocytopenia (HP:0001913) | 2.32781789 |
| 88 | Increased IgE level (HP:0003212) | 2.29873767 |
| 89 | Keratoconjunctivitis sicca (HP:0001097) | 2.26570718 |
| 90 | Papilloma (HP:0012740) | 2.25886706 |
| 91 | Verrucae (HP:0200043) | 2.25886706 |
| 92 | Purpura (HP:0000979) | 2.25075265 |
| 93 | Reticulocytopenia (HP:0001896) | 2.24846393 |
| 94 | Emphysema (HP:0002097) | 2.23010890 |
| 95 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.22665029 |
| 96 | Gingival bleeding (HP:0000225) | 2.22323216 |
| 97 | Hypochromic microcytic anemia (HP:0004840) | 2.21915747 |
| 98 | Abnormality of the pleura (HP:0002103) | 2.21675436 |
| 99 | Eosinophilia (HP:0001880) | 2.20712206 |
| 100 | Increased IgM level (HP:0003496) | 2.18667178 |
| 101 | Hypoproteinemia (HP:0003075) | 2.15598593 |
| 102 | Abnormality of the prostate (HP:0008775) | 2.15369010 |
| 103 | Fatigue (HP:0012378) | 2.12340253 |
| 104 | Slow saccadic eye movements (HP:0000514) | 2.11442794 |
| 105 | Recurrent bacterial skin infections (HP:0005406) | 2.09457309 |
| 106 | Interstitial pulmonary disease (HP:0006530) | 2.07905724 |
| 107 | Hypergammaglobulinemia (HP:0010702) | 2.06569149 |
| 108 | Episodic fever (HP:0001954) | 2.05859065 |
| 109 | Acute hepatic failure (HP:0006554) | 2.05359409 |
| 110 | Acute myeloid leukemia (HP:0004808) | 2.03840570 |
| 111 | Hypoplasia of the thymus (HP:0000778) | 2.03217101 |
| 112 | Keratoconjunctivitis (HP:0001096) | 2.02949086 |
| 113 | Sepsis (HP:0100806) | 2.02201025 |
| 114 | Glomerulopathy (HP:0100820) | 2.00560586 |
| 115 | Gastrointestinal infarctions (HP:0005244) | 1.96695449 |
| 116 | Pallor (HP:0000980) | 1.92422204 |
| 117 | Acne (HP:0001061) | 1.92356263 |
| 118 | Skin rash (HP:0000988) | 1.91711695 |
| 119 | Stomach cancer (HP:0012126) | 1.91701817 |
| 120 | Polycythemia (HP:0001901) | 1.90783218 |
| 121 | Abnormality of the endocardium (HP:0004306) | 1.89732520 |
| 122 | Polyneuropathy (HP:0001271) | 1.89233240 |
| 123 | Arthralgia (HP:0002829) | 1.87226709 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.46344610 |
| 2 | TXK | 4.82934034 |
| 3 | TIE1 | 3.40005309 |
| 4 | RIPK4 | 3.30629205 |
| 5 | TGFBR1 | 2.82882722 |
| 6 | ZAP70 | 2.81080246 |
| 7 | TGFBR2 | 2.77065635 |
| 8 | KDR | 2.72536532 |
| 9 | JAK3 | 2.71703525 |
| 10 | FGFR4 | 2.45724694 |
| 11 | IKBKE | 2.43997894 |
| 12 | ITK | 2.24567110 |
| 13 | KIT | 2.23435269 |
| 14 | TEC | 2.16367858 |
| 15 | STK10 | 2.12785510 |
| 16 | NME2 | 2.10679099 |
| 17 | TBK1 | 2.00838072 |
| 18 | PRPF4B | 1.97949965 |
| 19 | MAP3K14 | 1.96009709 |
| 20 | NLK | 1.95347872 |
| 21 | BTK | 1.90394204 |
| 22 | TYK2 | 1.86425071 |
| 23 | EEF2K | 1.73870296 |
| 24 | SYK | 1.62597903 |
| 25 | LCK | 1.59094143 |
| 26 | FGFR3 | 1.58180283 |
| 27 | MAP2K3 | 1.56481902 |
| 28 | CAMKK2 | 1.46504610 |
| 29 | JAK1 | 1.45508216 |
| 30 | IKBKB | 1.43654262 |
| 31 | LRRK2 | 1.41631860 |
| 32 | MAP3K13 | 1.31601444 |
| 33 | GRK6 | 1.29712796 |
| 34 | FGR | 1.26339429 |
| 35 | CAMKK1 | 1.22853756 |
| 36 | IRAK4 | 1.19234204 |
| 37 | HCK | 1.11875409 |
| 38 | CSK | 1.08850988 |
| 39 | FLT3 | 1.08624944 |
| 40 | BLK | 1.03323023 |
| 41 | CSF1R | 1.02718886 |
| 42 | MAP2K6 | 1.01914946 |
| 43 | MAP3K3 | 1.01590697 |
| 44 | PIM1 | 0.99530876 |
| 45 | LYN | 0.98492164 |
| 46 | MAP3K10 | 0.98446870 |
| 47 | ERN1 | 0.94702959 |
| 48 | RPS6KA4 | 0.92888252 |
| 49 | CLK1 | 0.91717516 |
| 50 | CHUK | 0.89048648 |
| 51 | FES | 0.88741672 |
| 52 | MUSK | 0.87732533 |
| 53 | PRKD2 | 0.85662965 |
| 54 | MAP3K1 | 0.81683934 |
| 55 | GRK7 | 0.81390083 |
| 56 | MAP3K12 | 0.80395793 |
| 57 | TYRO3 | 0.78217515 |
| 58 | MAP3K7 | 0.77617155 |
| 59 | PRKCH | 0.75623765 |
| 60 | PRKCQ | 0.71420655 |
| 61 | PKN2 | 0.68729323 |
| 62 | FYN | 0.68574522 |
| 63 | MST4 | 0.65103569 |
| 64 | IRAK3 | 0.63794111 |
| 65 | PASK | 0.63442868 |
| 66 | TAOK2 | 0.63224828 |
| 67 | RPS6KB2 | 0.63151575 |
| 68 | PRKG2 | 0.62021140 |
| 69 | BMPR2 | 0.60916014 |
| 70 | MARK3 | 0.60264158 |
| 71 | MATK | 0.57090188 |
| 72 | EPHA3 | 0.56762834 |
| 73 | CDC42BPA | 0.56381074 |
| 74 | SIK3 | 0.56170675 |
| 75 | TNK2 | 0.53478297 |
| 76 | JAK2 | 0.53372569 |
| 77 | PIM2 | 0.53146447 |
| 78 | HIPK2 | 0.52536532 |
| 79 | YES1 | 0.52133544 |
| 80 | SIK2 | 0.51913231 |
| 81 | TNIK | 0.51139412 |
| 82 | ACVR1B | 0.50167992 |
| 83 | TSSK6 | 0.48300129 |
| 84 | RIPK1 | 0.46291511 |
| 85 | PTK6 | 0.45306624 |
| 86 | PTK2B | 0.44331134 |
| 87 | EPHB1 | 0.44151559 |
| 88 | KSR2 | 0.42871990 |
| 89 | PDGFRB | 0.42780477 |
| 90 | CDK8 | 0.41622710 |
| 91 | CDK9 | 0.41418069 |
| 92 | MAPK12 | 0.40881440 |
| 93 | TAOK3 | 0.40596904 |
| 94 | MAPK11 | 0.40416058 |
| 95 | MARK2 | 0.40234657 |
| 96 | PDPK1 | 0.38248813 |
| 97 | STK38 | 0.37320403 |
| 98 | MAPK7 | 0.35772666 |
| 99 | TLK1 | 0.35319964 |
| 100 | PLK4 | 0.35122738 |
| 101 | SRPK1 | 0.34916073 |
| 102 | MAP3K11 | 0.34805931 |
| 103 | MYLK | 0.33369702 |
| 104 | MAP2K2 | 0.32899416 |
| 105 | RPS6KA5 | 0.32731649 |
| 106 | CDK4 | 0.32186316 |
| 107 | STK11 | 0.31465604 |
| 108 | MAPK4 | 0.31371174 |
| 109 | EGFR | 0.30254812 |
| 110 | MAP3K5 | 0.30042038 |
| 111 | PDK1 | 0.29788376 |
| 112 | MAPKAPK2 | 0.29468117 |
| 113 | RET | 0.29227546 |
| 114 | MAP3K6 | 0.28530958 |
| 115 | IGF1R | 0.28086091 |
| 116 | DYRK1B | 0.26122527 |
| 117 | PIK3CG | 0.24826332 |
| 118 | IRAK1 | 0.24386121 |
| 119 | CAMK1 | 0.24130149 |
| 120 | SIK1 | 0.23962124 |
| 121 | MAPK3 | 0.23866092 |
| 122 | GRK1 | 0.23409771 |
| 123 | CDK6 | 0.23222836 |
| 124 | ADRBK2 | 0.23180906 |
| 125 | ABL1 | 0.21420396 |
| 126 | ATR | 0.20770753 |
| 127 | RAF1 | 0.20057968 |
| 128 | TRIB3 | 0.20032945 |
| 129 | TAOK1 | 0.19192699 |
| 130 | INSR | 0.18707316 |
| 131 | TESK2 | 0.18485276 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.97797041 |
| 2 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.94356653 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 2.82228897 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.80940240 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.78996591 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.66454069 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.59204151 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.54009007 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.42123990 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.42094859 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.41253939 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.37823124 |
| 13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.30563357 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.16373882 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.02515254 |
| 16 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.99749893 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.96665339 |
| 18 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.71528783 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.70374756 |
| 20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.68104501 |
| 21 | Shigellosis_Homo sapiens_hsa05131 | 1.45642200 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.43872712 |
| 23 | Viral myocarditis_Homo sapiens_hsa05416 | 1.41321203 |
| 24 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.38953230 |
| 25 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.36933804 |
| 26 | Platelet activation_Homo sapiens_hsa04611 | 1.36754635 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.34419626 |
| 28 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.32991553 |
| 29 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.30607107 |
| 30 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.23637684 |
| 31 | Malaria_Homo sapiens_hsa05144 | 1.23258537 |
| 32 | Base excision repair_Homo sapiens_hsa03410 | 1.23016379 |
| 33 | DNA replication_Homo sapiens_hsa03030 | 1.20474723 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.19691027 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 1.19000018 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.15297205 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.13697409 |
| 38 | Mismatch repair_Homo sapiens_hsa03430 | 1.08116560 |
| 39 | Spliceosome_Homo sapiens_hsa03040 | 1.07855722 |
| 40 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.05988208 |
| 41 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.05570805 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 1.04361642 |
| 43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.02797767 |
| 44 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.99642938 |
| 45 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.98387358 |
| 46 | HTLV-I infection_Homo sapiens_hsa05166 | 0.98041139 |
| 47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.96000962 |
| 48 | Asthma_Homo sapiens_hsa05310 | 0.95667861 |
| 49 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.89751868 |
| 50 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.87980779 |
| 51 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.87400856 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 0.86582300 |
| 53 | Pertussis_Homo sapiens_hsa05133 | 0.85180989 |
| 54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.85131602 |
| 55 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.83054052 |
| 56 | RNA degradation_Homo sapiens_hsa03018 | 0.82984748 |
| 57 | Legionellosis_Homo sapiens_hsa05134 | 0.82866842 |
| 58 | Phagosome_Homo sapiens_hsa04145 | 0.81784680 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77187136 |
| 60 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.70727138 |
| 61 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.69695378 |
| 62 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.69234131 |
| 63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69055574 |
| 64 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.66160520 |
| 65 | Salmonella infection_Homo sapiens_hsa05132 | 0.65997175 |
| 66 | Colorectal cancer_Homo sapiens_hsa05210 | 0.65618261 |
| 67 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64658149 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64469816 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.64114680 |
| 70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.64028777 |
| 71 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.61187927 |
| 72 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.59448729 |
| 73 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.59383758 |
| 74 | Endocytosis_Homo sapiens_hsa04144 | 0.59374856 |
| 75 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.57750649 |
| 76 | RNA polymerase_Homo sapiens_hsa03020 | 0.57714181 |
| 77 | Thyroid cancer_Homo sapiens_hsa05216 | 0.57162378 |
| 78 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.55443248 |
| 79 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.55303288 |
| 80 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.54237175 |
| 81 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54188805 |
| 82 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.54081430 |
| 83 | Tuberculosis_Homo sapiens_hsa05152 | 0.53450032 |
| 84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53269364 |
| 85 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.53085536 |
| 86 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.47678920 |
| 87 | Homologous recombination_Homo sapiens_hsa03440 | 0.47284203 |
| 88 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45401057 |
| 89 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45275212 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.45139636 |
| 91 | Lysosome_Homo sapiens_hsa04142 | 0.44636119 |
| 92 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42300937 |
| 93 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41814525 |
| 94 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.41379223 |
| 95 | Proteasome_Homo sapiens_hsa03050 | 0.40410479 |
| 96 | Sulfur relay system_Homo sapiens_hsa04122 | 0.39899660 |
| 97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38148797 |
| 98 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38135331 |
| 99 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.37394778 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.36755689 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36503475 |
| 102 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35779412 |
| 103 | Insulin resistance_Homo sapiens_hsa04931 | 0.34896014 |
| 104 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.33310117 |
| 105 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.32642429 |
| 106 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.32055117 |
| 107 | Other glycan degradation_Homo sapiens_hsa00511 | 0.31967205 |
| 108 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.31774496 |
| 109 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.31541295 |
| 110 | Basal transcription factors_Homo sapiens_hsa03022 | 0.31303418 |
| 111 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.31206218 |
| 112 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30534355 |
| 113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29361229 |
| 114 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.28659741 |
| 115 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28463962 |
| 116 | RNA transport_Homo sapiens_hsa03013 | 0.27077254 |
| 117 | Pathways in cancer_Homo sapiens_hsa05200 | 0.26751761 |
| 118 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25901907 |
| 119 | Amoebiasis_Homo sapiens_hsa05146 | 0.24662064 |
| 120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.24064533 |
| 121 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.22473630 |
| 122 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.21873146 |
| 123 | Cell cycle_Homo sapiens_hsa04110 | 0.21519699 |
| 124 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.20818902 |
| 125 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.20769032 |
| 126 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.19953672 |
| 127 | Protein export_Homo sapiens_hsa03060 | 0.18716909 |
| 128 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.18702300 |

